The Cosmetic Products Regulation (EC) No 1223/2009 (Restriction of Chemical Substances) (Amendment and Transitional Provisions) (No. 2) Regulations 2026

Type Statutory-Instrument
Publication 2026-02-04
State In force
Department King's Printer of Acts of Parliament
PDF Download
articles Not indexed
Reform history JSON API

Made: 4th February 2026

Laid before Parliament: 9th February 2026

Coming into force in accordance with regulation 1(2) and (3)

The Secretary of State makes these Regulations in exercise of the powers conferred by Articles 31(1)(f), 31(1)(g)(i) and 32(1) of Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products[^f00001] (“the Cosmetic Regulation”).

In accordance with Article 31(1)(f) of the Cosmetic Regulation, the substances set out in Schedule 1 to these Regulations have been classified as CMR[^f00002] substances of category 1B or 2 under Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures[^f00003] (“the CLP Regulation”).

In accordance with Article 31(1)(g)(i) of the Cosmetic Regulation, hexyl 2-hydroxybenzoate has been classified as a CMR substance of category 2 under the CLP Regulation and the Secretary of State considers there is sufficient scientific evidence that this substance is safe for use in cosmetic products.

Citation, commencement, extent and interpretation

1

Amendments to the Cosmetic Regulation

2

Transitional Provisions

3

Schedule 1 — Entries to be inserted into Annex 2

“1761 Sodium 3-(allyloxy)-2-hydroxypropanesulphonate 52556-42-0 258-004-5
1762 N,N’-Methylenediacrylamide 110-26-9 203-750-9
1763 Reaction mass of 1,3-dioxan-5-ol and 1,3-dioxolan-4-ylmethanol
1764 1,4-Dichloro-2-nitrobenzene 89-61-2 201-923-3
1765 Pyraclostrobin (ISO); methyl N-{]2-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxymethyl}phenyl[} N-methoxy carbamate 175013-18-0 605-747-1
1766 Tert-Butyl 2-ethylperoxyhexanoate 3006-82-4 221-110-7
1767 Fenpropidin (ISO); (R,S)-1-[3-(4-tert-butylphenyl)-2- methylpropyl]piperidine 67306-00-7
1768 2-Ethylhexanoic acid, monoester with propane-1,2-diol 85114-00-7 285-503-5
1769 α,α’-Propylenedinitrilodi-o-cresol 94-91-7 202-374-2
1770 Ozone 10028-15-6 233-069-2
1771 2-Phenylpropene; α-methylstyrene 98-83-9 202-705-0
1772 Silver (nano) [particle diameter > 1 nm ≤ 100 nm] Silver (massive) [particle diameter ≥ 1 mm] 7440-22-4 231-131-3
1773 Dinitrogen oxide 10024-97-2 233-032-0”

Schedule 2 — Entry to be inserted into Annex 3

“325 Hexyl 2-hydroxybenzoate Hexyl Salicylate 6259-76-3 228-408-6 (a) Fragrance products (spray and non-spray) (b) Rinse-off skin and hair products (c) Leave-on skin products (except fragrance products, face makeup products, lip products and deodorants (spray and non-spray)) (d) Lip products (e) Deodorant (spray and non-spray) (f) Leave-on hair products (spray and non-spray) (g) Face makeup products (h) Toothpaste and mouthwash (i) Nail products (a) (1) 0.1% (products intended for children 0–3 years) (2) 2% (products intended for children above 3 years and adults) (b) (1) 0.1% (products intended for children 0–3 years) (2) 0.5% (products intended for children above 3 years and adults) (c) (1) 0.1% (products intended for children 0–3 years) (2) 0.3% (products intended for children above 3 years and adults) (d) (1) 0.1% (products intended for children 0–3 years) (2) 0.3% (products intended for children above 3 years and adults) (e) 0.3% (products intended for children above 3 years and adults) (f) 0.3% (products intended for children above 3 years and adults) (g) 0.3% (products intended for children above 3 years and adults) (h) 0.001% (i) 0.5% (products intended for children above 3 years and adults)”

Signed

Kate Dearden — Parliamentary Under-Secretary of State — Department for Business and Trade — 4th February 2026

Explanatory note

(This note is not part of the Regulations)

Explanatory Note

These Regulations amend Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (“the Cosmetic Regulation”) to prohibit or restrict the use of certain substances in cosmetic products.

Regulation 2(2) and Schedule 1 amend Annex 2 to the Cosmetic Regulation (list of substances prohibited in cosmetic products) to add substances that have been classified as category 1B or 2 carcinogenic, mutagenic or toxic for reproduction (“CMR”) substances under Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures, prohibiting these substances from use in cosmetic products. This amendment applies from 23rd March 2027.

Regulation 2(3) and Schedule 2 amend Annex 3 to the Cosmetic Regulation (list of substances which cosmetic products must not contain except subject to the restrictions laid down) to add hexyl 2-hydroxybenzoate (commonly known as “hexyl salicylate”) to restrict its use in cosmetic products, to ensure that different types of cosmetic products contain safe levels of hexyl salicylate in accordance with advice from the Scientific Advisory Group on Chemical Safety of Non-Food and Non-Medicinal Consumer Products. This amendment applies from 15th August 2026.

Regulation 3 sets out the transitional arrangements for cosmetic products containing these substances.

A full impact assessment has not been produced for this instrument as no, or no significant, impact on the private, voluntary or business sectors is foreseen. An Explanatory Memorandum is published alongside these Regulations on www.legislation.gov.uk.

Footnotes

[^f00001]: EUR 2009/1223; relevant amending instruments are S.I. 2022/659, 2023/836, 2024/455, 2024/1334, 2025/413 and 2026/23.

[^f00002]: For the definition of “CMR” see Article 2(1)(va) of Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products.

[^f00003]: EUR 2008/1272, to which there are amendments not relevant to these Regulations.

Reading this document does not replace reading the official text published on legislation.gov.uk. Contains public sector information licensed under the Open Government Licence v3.0. We assume no responsibility for any inaccuracies arising from the conversion of the original CLML XML to this format.

This text is published under legislation.gov.uk's own terms of reuse, not a Legalize or public-domain licence. legislation.gov.uk
Open Government Licence v3.0 (attribution required)
© Crown and database right. Derived from content available under the Open Government Licence v3.0 from legislation.gov.uk.